Key Players
Competitive Landscape
Competition in savory oral nutrition supplements separates direct soup or savory ONS companies from broader clinical nutrition groups with prescribing relationships. Direct specialists compete on taste direction and meal fit while larger portfolios compete on evidence support and channel access. Buyers still compare nutrient density plus serving burden before adding another format to a formulary.
During 2025 specialized nutrition companies broadened access and external research links as Danone agreed in May to acquire a majority stake in Kate Farms and extend North American medical nutrition reach. Nestlé Health Science added university innovation collaborations in November to advance nutrition research in the United States and Australia. New savory formats still require exact-product validation before routine prescribing can convert research activity into clinical use.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In January 2026, Nestlé integrated Nestlé Health Science into its geographic Nutrition businesses as the new operating structure took effect. | Healthcare systems increasingly expect nutrition suppliers to support clinical use within larger regional service structures. | Medical nutrition is being managed closer to regional nutrition businesses rather than as a separate global unit. | Shared regional infrastructure can shorten commercial handoffs for new ONS formats where local evidence and prescribing routes already exist. |
| In January 2026, AYMES added two new Actagain Crème flavors within its medically supervised nutrition range. | Patients using ONS for longer periods need sensory alternatives that preserve the prescribed nutrition objective. | Suppliers are extending flavor choice inside existing medical nutrition families instead of relying on one dominant taste profile. | The same product-development capability can support savory extensions where formularies accept a different meal-compatible taste direction. |
| In September 2026, Meiji launched two new soft-jelly flavors in its MeiBalance nutrition range for nationwide sale in Japan. | Small-volume nutrition users may need texture options that fit reduced appetite or easier spoon-based intake. | Clinical and care nutrition brands are extending compact formats beyond conventional liquid drinks. | Savory semi-solid formats could address the same serving need where local buyers require meal-compatible taste and controlled texture. |
Regional medical nutrition brands also compete for hospital and care-home accounts where local formularies favor clinically supported ONS choices.
Source: Future Market Insights, Savory Oral Nutrition Supplement Market Report, 2026-2036.
The represented companies cover direct savory products plus clinical ONS portfolios and compact formats used in medically supervised nutrition.
Who leads the savory oral nutrition supplement market?
No disclosed market-share dataset provides a defensible single-company ranking for this narrow category alone. Danone Nutricia, Meiji Co., Ltd., and AYMES each sell direct savory or soup-style oral nutrition products.
Which suppliers have documented qualification or quality approvals?
Meiji documents Japanese special-dietary-food authorization for its Soup Taste Series within a nationally regulated nutrition category. European ONS portfolios from Danone Nutricia and Fresenius Kabi are sold for medical use under professional supervision.
Which companies provide soup-style or meal-compatible oral nutrition products?
Danone Nutricia, Meiji Co., Ltd., and AYMES provide direct savory formats for medically supervised nutrition. Nestlé Health Science also supplies nutritionally complete soup-format medical nutrition within its Resource range.
Which suppliers serve European and North American clinical nutrition channels?
Danone Nutricia, Nestlé Health Science, Fresenius Kabi, Abbott, and Medtrition serve clinical nutrition channels spanning Europe and North America.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Danone Nutricia | Direct savory medical nutrition supplier with warm-serving Fortimel options and established clinical nutrition channels. | In July 2025, Danone completed its majority acquisition of Kate Farms and expanded its USA specialized nutrition business. |
| Nestlé Health Science | Global medical nutrition business with soup-format capability and a broad oral nutrition portfolio. | In February 2026, Nestlé documented the Onavida clinical trial of Meritene Clinical Extra Protein across 18 Spanish hospitals and more than 230 patients. |
| AYMES | UK oral medical nutrition specialist with a direct savory powder product and multiple compact formats. | In February 2025, AYMES moved ActaGain 1.5 Complete into Tetra Pak packaging while retaining its prescribing codes. |
| Meiji Co., Ltd. | Japanese nutrition company with direct soup-style MeiBalance products and compact oral nutrition formats. | In September 2026, Meiji launched a HighPro MeiBalance Mini Cup range with two compact high-protein flavors nationwide. |
| Nualtra | Medical nutrition company serving UK and Irish clinical channels with liquid, powder, and semi-solid ONS formats. | In May 2025, Nualtra launched Altrini Compact Fibre as its first pediatric oral nutritional supplement under Ajinomoto ownership. |
| Fresenius Kabi | Clinical nutrition supplier with oral supplements and established medical nutrition distribution in European markets. | In December 2025, Fresenius Kabi reported launching Fresubin PLANT-BASED Drink as an oral nutritional supplement for patient choice and compliance. |
| Medtrition | Institutional nutrition specialist supplying oral protein products to acute and long-term care channels. | In March 2025, Medtrition launched the ProSource Cup portfolio and scheduled national-account availability from April 2025. |
| Abbott | Adult oral nutrition supplier with institutional Ensure products; the current portfolio does not document a savory therapeutic line. | In May 2026, Abbott launched Ensure Strength Pro in India as a new adult nutrition formula designed to support healthy aging. |
Research Methodology
The companies mapped here illustrate competition between direct savory ONS and broader clinical nutrition portfolios serving the same care settings. Inclusion requires an oral medical nutrition role plus a dated action tied to the product family or clinical purchase route. Official company announcements and national prescribing records provide the evidence used for each listed development and market position. Direct savory products receive narrower positioning than broader ONS portfolios because product fit must match the stated market boundary. Company actions are attributed to the named product or business line rather than the full corporate portfolio. Market-share estimates remain proprietary FMI assessments covering the 2026 to 2036 forecast period and do not imply public rankings.
